Related Experiment Video
Updated: May 27, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Intracellular pathways of pancreatic β-cell apoptosis in type 1 diabetes
1St Vincent's Institute of Medical Research, Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Melbourne, Victoria, Australia. hthomas@svi.edu.au
Background:
Apoptosis of β cells is a feature of type 1 diabetes. It is also increasingly recognized in type 2 diabetes and islet graft rejection.
Methods:
We have studied the intracellular pathways that regulate β-cell apoptosis in type 1 and 2 diabetes. We have examined the role of Bid, a pro-apoptotic member of the Bcl-2 family, using islets from mice deficient in Bid. We also studied the Bcl-2 family molecules involved in killing by using high concentrations of reducing sugars such as glucose or ribose.
Results:
We found that Bid-deficient islets are protected from recombinant human perforin and granzyme B, as well as from Fas-mediated killing. This makes Bid a target for protection of β cells from multiple insults relevant to type 1 diabetes. In contrast to granzyme B and death receptor signalling, we found that islets lacking Bim or Puma were protected from glucose toxicity.
Conclusions:
Our data indicate that different stimuli activate different initiator molecules in the Bcl-2-regulated pathway in β cells.
Insights
Bid protein protects beta cells from diabetes-related damage. Targeting Bid may prevent beta cell death in type 1 diabetes and islet transplantation. This research clarifies apoptosis pathways in diabetes.
Area of Science:
- Molecular Biology
- Endocrinology
- Immunology
Background:
- Beta cell apoptosis is a hallmark of type 1 diabetes.
- Beta cell loss is also observed in type 2 diabetes and islet graft rejection.
Purpose of the Study:
- To investigate intracellular pathways regulating beta cell apoptosis in diabetes.
- To examine the role of Bid, a pro-apoptotic Bcl-2 family member, in beta cell death.
- To identify Bcl-2 family molecules involved in killing induced by high glucose concentrations.
Main Methods:
- Studied intracellular pathways regulating beta cell apoptosis in type 1 and type 2 diabetes.
- Utilized islets from Bid-deficient mice to assess Bid's role.
- Investigated Bcl-2 family molecules involved in cell death induced by high glucose or ribose.
Main Results:
- Bid-deficient islets showed protection against perforin, granzyme B, and Fas-mediated killing.
- Bid deficiency offers a potential therapeutic target for protecting beta cells from type 1 diabetes insults.
- Islets lacking Bim or Puma, but not Bid, were protected from glucose toxicity.
Conclusions:
- Different stimuli activate distinct initiator molecules within the Bcl-2-regulated apoptosis pathway in beta cells.
- Bid plays a crucial role in mediating beta cell apoptosis induced by immune and cytotoxic insults relevant to type 1 diabetes.
- Bim and Puma are key mediators of glucose-induced beta cell toxicity.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Insulin Secretory Vesicles

